SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-18-000005
Filing Date
2018-05-10
Accepted
2018-05-10 16:39:17
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q1x2018.htm 10-Q 811022
2 EXHIBIT 10.4 exhibit104q12018.htm EX-10.4 75344
3 EXHIBIT 31.1 exhibit311q12018.htm EX-31.1 9696
4 EXHIBIT 31.2 exhibit312q12018.htm EX-31.2 9659
5 EXHIBIT 32.1 exhibit321q12018.htm EX-32.1 10011
  Complete submission text file 0000827871-18-000005.txt   5146881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT egrx-20180331.xml EX-101.INS 887776
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20180331.xsd EX-101.SCH 39618
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20180331_cal.xml EX-101.CAL 93959
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20180331_def.xml EX-101.DEF 217311
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20180331_lab.xml EX-101.LAB 548015
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20180331_pre.xml EX-101.PRE 368156
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 18823176
SIC: 2834 Pharmaceutical Preparations